AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TEMOZOLOMIDE
23 registrations across 5 African markets— 21 active
Markets with TEMOZOLOMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TEMORO CAPSULE; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Feb 2030 |
| TEMORO CAPSULE; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| TEMOTERO_20 20MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2020 |
| TEMOTERO_250 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2020 |
| TEMODAL 180 mg CAPSULES | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| TEMODAL 140 mg CAPSULES | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| TEMODAL 250 mg CAPSULES | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| TEMINTAS 5 | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| TEMINTAS 20 | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| TEMODAL 20 mg CAPSULES | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| TEMODAL 100 mg CAPSULES | 🇿🇦South Africa | MSD (Pty) Ltd | active | Jan 1900 |
| ACCORD-TEMOZOLOMIDE 5 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| TEMINTAS 250 | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| ACCORD-TEMOZOLOMIDE 20 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| ACCORD-TEMOZOLOMIDE 250 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| ACCORD-TEMOZOLOMIDE 100 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| TEMINTAS 100 | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| TEMODAL GELULE | 🇲🇦Morocco | — | active | — |
| TEMODAL GELULE | 🇲🇦Morocco | — | active | — |
| TEMODAL GELULE | 🇲🇦Morocco | — | active | — |
| TEMODAL GELULE | 🇲🇦Morocco | — | active | — |
| TEMOZOLOMIDE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | HETERO LABS LTD | active | — |
| TEMOZOLOMIDE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | HETERO LABS LTD | active | — |
TEMOZOLOMIDE in Africa — Regulatory Overview
TEMOZOLOMIDE is registered across 5 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Malawi, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 21 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.